肥満に関連したインスリン抵抗性と免疫システムの相互作用は,進化医学のレンズを通して見ることができます
Maryam Moazzam-Jazi1, Saeideh Jafarinejad-Farsangi2, Leila Najd-Hassan-Bonab1
1Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Molecular metabolism
|February 15, 2026
まとめ
インスリン抵抗性 (IR) は,保存された特徴であり,歴史的に免疫系を活性化することによって生存を助長しました. 現代のライフスタイルは,炎症や代謝疾患につながる,持続的なIRを引き起こします.
科学分野:
- 進化医学とは,進化医学である.
- 免疫学 免疫学とは
- メタボリック障害 メタボリック障害
背景:
- インスリン抵抗性 (IR) は,現代のヒトの代謝および免疫障害に関連しています.
- IRは進化的に保存された特徴であり,祖先の生存の利点を示唆しています.
- 古代の人々は,生存のためにエネルギー貯蔵と免疫活性化を活用しました.
研究 の 目的:
- IRと免疫系との相互作用を探求する.
- 免疫代謝およびアレルギー性疾患への影響を検証する.
- IRと現代の病気に関する進化的視点を提供するために.
主な方法:
- 進化医学原理のレビュー 進化医学原理のレビュー
- エネルギー貯蔵と免疫機能におけるインスリンの役割の分析.
- IRと免疫相互作用に関連したゲノム領域の検査.
主要な成果:
- IRは歴史的にグルコースを免疫系に誘導し,食糧不足の時に生き残った.
- 現代のライフスタイルは,低度の炎症を引き起こす持続的なIRを促進します.
- 祖先の環境と現代の環境の進化的不一致は,病気の感受性に寄与する.
結論:
- 現代のライフスタイルにおける持続的なIRは,炎症や免疫代謝障害を引き起こす.
- IRの進化的基礎を理解することは,免疫-代謝のクロストラックを標的とした治療戦略を伝える.
- PTEN,IL27,およびNUPR1の近くのゲノム領域は,IR-免疫相互作用にとって決定的かもしれません.
関連する概念動画
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Psychoneuroimmunology: Diabetes and Cancer
513
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
513
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
197
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
197
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
301
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
301
Insulin: The Receptor and Signaling Pathways
3.5K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.5K
Drug Dosing: Obese Patients
275
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
275


